Emerging Tumor Biomarkers in Pancreatic Cancer and Their Clinical Implications

Dimitrios Stefanoudakis(APLA Health), Konstantinos G. Toutouzas(Hippocration General Hospital), Nikolaos V. Michalopoulos(National and Kapodistrian University of Athens), Dimitriοs Schizas(Laiko General Hospital of Athens), Maximos Frountzas(Royal Marsden NHS Foundation Trust), Dimitrios Theodorou(National and Kapodistrian University of Athens)
Current Issues in Molecular Biology
May 10, 2025
10.3390/cimb47050347
Cited by 2

Related Papers

Tumor Markers and Their Diagnostic Significance in Ovarian Cancer
|Life|2023|78
Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
|Current Issues in Molecular Biology|2024|78
The Potential Revolution of Cancer Treatment with CRISPR Technology
|Cancers|2023|63
Immunotherapy in Cervical and Endometrial Cancer: Current Landscape and Future Directions
|Life|2024|25
VEGF inhibition in urothelial cancer: the past, present and future
|World Journal of Urology|2020|19